Hashimoto’s Disease: Causes, Progression, and Treatment

Hashimoto’s thyroiditis is the most common cause of hypothyroidism in countries with adequate iodine intake, and it is an autoimmune disease in which the body’s own immune system gradually damages the thyroid gland. It affects women far more often than men, progresses through distinct phases that can confuse both patients and doctors, and frequently leaves people feeling unwell even after their lab numbers look normal. The condition is more layered than the standard “take a pill and you’re fine” narrative suggests.

What Actually Happens Inside the Thyroid

Hashimoto’s is driven by immune cells that infiltrate the thyroid and slowly destroy it. The thyroid tissue fills with lymphocytes, which form clusters resembling the structures you’d normally see in a lymph node, not a hormone-producing gland.¹ Both arms of the immune system are involved: immune cells attack thyroid tissue directly, and antibodies produced by other immune cells mark it for destruction.² Over time, the thyroid follicles that produce hormones shrink, get trapped inside the immune infiltrate, and are eventually destroyed. The cells that survive often change their appearance, becoming larger and grainier in a transformation known as Hürthle cell metaplasia.³ The practical result is a thyroid that gradually loses its ability to make enough hormones.

Why Some People Get It and Others Don’t

There is no single cause. Hashimoto’s arises from a combination of genetic susceptibility, hormonal factors, and environmental triggers that collectively push the immune system to turn on the thyroid.

On the genetic side, several gene variants have been linked to increased risk. Variations in the CTLA-4 gene, which helps regulate immune responses, show a positive association with the disease.⁴ The thyroglobulin gene on chromosome 8 is another strong candidate, which makes sense given that thyroglobulin, the protein the thyroid uses to build its hormones, is a major target of the autoimmune attack.⁵ But genes alone don’t explain why this disease is so lopsided in who it affects.

The most striking risk factor is being female. Sex hormones, particularly estrogen, appear to alter both the number and behavior of immune cells in ways that promote autoimmunity against the thyroid.⁶ Estrogen can stimulate thyroid antibody production and affect the signaling axis between the brain and the thyroid. Animal models confirm this sex difference: female rats are more susceptible to autoimmune thyroiditis than males, and the difference tracks with hormonal influences on the immune system.⁷

The Iodine Paradox

Iodine is essential for making thyroid hormones, yet too much of it can trigger Hashimoto’s in susceptible people. Chronic excess iodine intake makes thyroglobulin more recognizable to the immune system, essentially turning a normal thyroid protein into a more potent target.⁸ Lab research has shown that excess iodine also directly damages thyroid cells by suppressing a protective recycling process within the cells, leading to increased cell death.⁹ This doesn’t mean you should avoid iodine altogether. Iodine deficiency causes its own serious problems, including goiter and cognitive impairment. The risk lies in going well beyond what the thyroid needs, which can happen with heavy use of iodine supplements, kelp products, or certain medications like amiodarone.¹⁰

How Hashimoto’s Progresses Through Phases

Hashimoto’s doesn’t always start with an underactive thyroid. In fact, many people’s first experience with the disease is the opposite. As the immune attack begins destroying thyroid follicles, stored hormones spill into the bloodstream, creating a temporary state of excess thyroid hormone. This phase, called hashitoxicosis, can produce symptoms like a racing heart, anxiety, weight loss, heat intolerance, and tremors. It usually lasts one to two months, though cases lasting much longer have been documented.¹¹

After the stored hormones are depleted, many patients enter a middle ground where the remaining healthy thyroid tissue compensates for what’s been destroyed, keeping hormone levels normal. This euthyroid phase can last years, even decades. During this time you feel fine and blood tests look normal, but antibodies are often detectable and the immune process is quietly continuing. Eventually, if enough thyroid tissue is lost, hormone production falls short and overt hypothyroidism develops, bringing the familiar symptoms of fatigue, weight gain, cold intolerance, constipation, and brain fog.¹² Not every patient travels the full arc. Some skip the hyperthyroid phase entirely. Others remain euthyroid for life.

How It’s Diagnosed

Diagnosis usually rests on two pillars: blood tests for thyroid antibodies and an ultrasound of the thyroid. The two main antibodies are anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg). When these antibodies are positive and the ultrasound shows the characteristic patchy, hypoechoic texture of an inflamed thyroid, the diagnosis is straightforward.

The tricky part is that neither test is especially sensitive on its own. Ultrasound, while highly specific (meaning that when it looks like Hashimoto’s, it almost certainly is), picks up only about a third of confirmed cases.¹³ Antibody testing has a similar pattern. One cross-sectional study found that both ultrasound and serum antibodies demonstrated high specificity but individually low sensitivity for Hashimoto’s, and even combining the two methods did not dramatically improve the detection rate.¹⁴ In practice, this means some people with early or mild Hashimoto’s get negative test results and may be told nothing is wrong. If symptoms persist, repeat testing or thyroid biopsy can help clarify the picture.

Ultrasound becomes more useful as the disease advances. Thyroid fibrosis, a sign of more severe and longstanding disease, correlates with higher anti-TPO levels and increased medication needs.¹⁵

Treatment With Levothyroxine

The standard treatment for Hashimoto’s hypothyroidism is levothyroxine, a synthetic version of the T4 hormone the thyroid normally produces. It effectively brings hormone levels back to normal, lowers TSH, and resolves many hypothyroid symptoms.¹⁶ Treatment is generally started when TSH is consistently elevated or when hypothyroid symptoms are present, even if the hypothyroidism is technically “subclinical” (meaning TSH is high but T4 is still in range).

A sizable group of patients, however, continues to feel unwell despite normal lab numbers on levothyroxine. Persistent fatigue, cognitive difficulties, mood changes, and a general feeling of being “off” remain common complaints even when TSH has been brought into the target range.¹⁷ This disconnect between lab values and how patients feel is one of the most frustrating aspects of the disease and has driven interest in alternative treatment approaches.

The T3 Combination Therapy Debate

Your body normally converts T4 into T3, the more active thyroid hormone. Some researchers have hypothesized that people with Hashimoto’s may not convert T4 to T3 efficiently, and that adding T3 directly could help persistent symptoms. This has led to trials of combination T4+T3 therapy.

The results are genuinely mixed. A systematic review and meta-analysis found that combination therapy did produce higher T3 levels in the blood and scored better on one measure of general health.¹⁸ But a separate meta-analysis specifically examining psychological outcomes found no measurable difference between combination therapy and T4 alone for depression, fatigue, pain, anxiety, or anger, even though patients tended to prefer the combination.¹⁹ The patient preference finding is interesting and hard to dismiss, but the objective symptom scores don’t clearly support the switch. For now, combination therapy remains an option to discuss with an endocrinologist if symptoms persist, but it is not a reliably superior treatment.²⁰

Selenium, Vitamin D, and Gluten-Free Diets

Few topics in Hashimoto’s generate more online advice than diet and supplements. Some of it has a real evidence base; much of it does not.

Selenium supplementation has the strongest track record for lowering thyroid antibody levels. A randomized controlled trial found that six months of selenium significantly lowered both anti-TPO and anti-Tg antibodies compared to a control group.²¹ An overview of systematic reviews confirmed the pattern: selenium reduces anti-TPO antibodies at three and six months in both people taking levothyroxine and those not on medication. After 12 months, though, the effect fades.²² Stopping selenium seems to partially reverse the benefit. One study showed that after 12 months of treatment, anti-TPO levels had dropped by about 21%, but a portion of that decrease bounced back when supplementation was discontinued.²³ The key caveat: lower antibody levels don’t automatically translate into feeling better or needing less medication. The clinical significance of reduced antibodies on their own remains unclear.

Vitamin D deficiency has been linked to a higher prevalence of thyroid autoimmunity, and some research suggests supplementation can lower antithyroid antibodies and shift immune markers in a favorable direction.²⁴ Lower vitamin D levels have been found to correlate with higher antibody titers and smaller thyroid volume in Hashimoto’s patients.²⁵ Still, the evidence isn’t strong enough to say that taking vitamin D will change the course of the disease. Correcting a deficiency makes sense for overall health; expecting it to treat Hashimoto’s specifically is getting ahead of the data.

Gluten-free diets are heavily promoted in Hashimoto’s circles online, but a review of the available literature found no basis for recommending a gluten-free diet as standard management. The exception is people who have confirmed celiac disease, which does co-occur with Hashimoto’s more often than in the general population. For everyone else, an anti-inflammatory diet that ensures adequate vitamin D, iodine, and selenium is a more evidence-based starting point.²⁶

The Gut Connection

A growing area of research involves the gut’s role in triggering or worsening Hashimoto’s. Increased intestinal permeability, sometimes called “leaky gut,” has been linked to the development of autoimmune disease because it allows molecules to cross the intestinal barrier and provoke immune responses.²⁷ Studies have found elevated zonulin, a protein that regulates intestinal permeability, in Hashimoto’s patients. Additionally, stool analyses have shown shifts in gut bacteria, with lower levels of beneficial butyrate-producing species and higher levels of potentially problematic bacteria.²⁸ This research is still early, and no specific probiotic or gut-targeted therapy has been validated for Hashimoto’s in large trials, but it points to the gut as a potential modifiable factor.

Pregnancy and Thyroid Antibodies

Hashimoto’s adds real complexity to pregnancy planning. Even when thyroid function is normal, the presence of thyroid antibodies alone is associated with a substantially higher risk of miscarriage. A meta-analysis of cohort studies found that women with thyroid autoantibodies had roughly four times the odds of miscarriage compared to antibody-negative women, and about twice the odds of preterm birth.²⁹ Two randomized studies included in that analysis showed that levothyroxine treatment reduced miscarriage risk by about half.

However, the picture isn’t entirely settled. A later randomized trial specifically examining women with normal thyroid function who had thyroid autoimmunity while undergoing IVF found no difference in miscarriage rates, pregnancy rates, or live-birth rates between those given levothyroxine and those given a placebo.³⁰ The difference may come down to population: the earlier studies often included women with mildly elevated TSH, while the JAMA trial was restricted to women with fully normal thyroid function. Current practice generally leans toward monitoring TSH closely during pregnancy and treating promptly if it rises, especially in women known to have thyroid antibodies.

When Children Are Affected

Hashimoto’s is the leading cause of acquired hypothyroidism in children, and here the stakes extend beyond fatigue and weight gain. Growth arrest is a frequent presenting symptom, with many affected children falling below the third percentile for height at diagnosis.³¹ Starting levothyroxine typically triggers catch-up growth, but the amount of recovery depends heavily on timing. Children diagnosed before puberty tend to catch up more completely. Those diagnosed during puberty face a narrower window because the growth plates are already closing, and even with treatment, many do not reach the height predicted by their genetics.³² This makes early recognition in children especially important. A child who was growing normally and then stalls should have thyroid function checked, particularly if there is a family history of autoimmune disease.

Complications Beyond the Thyroid

Hashimoto’s isn’t just a thyroid problem. The autoimmune process appears to have broader metabolic effects. Even in patients whose thyroid function is normal, the presence of high antibody levels has been linked to unfavorable cholesterol profiles. One study found that euthyroid Hashimoto’s patients had significantly higher LDL, triglycerides, and total cholesterol than healthy controls, and that antibody levels correlated positively with the degree of cholesterol elevation.³³ This suggests that the autoimmune inflammation itself, not just the lack of thyroid hormone, may contribute to cardiovascular risk.

A rare but serious complication is primary thyroid lymphoma, a cancer of the immune cells within the thyroid. People with Hashimoto’s have an estimated 40 to 80 times higher risk of developing this cancer compared to those without the disease.³⁴ Even with that dramatic relative increase, thyroid lymphoma remains very uncommon in absolute terms because the baseline rate is so low. A rapidly growing thyroid nodule in someone with longstanding Hashimoto’s, however, warrants prompt evaluation.

Perhaps the most underappreciated complication is polyautoimmunity, meaning the development of additional autoimmune diseases. A meta-analysis found that roughly 13% of people with autoimmune thyroid disease also had a second diagnosable autoimmune condition, most often type 1 diabetes or autoimmune gastritis. An additional 17% had detectable autoantibodies against other tissues, meaning they were on the road toward a second autoimmune disease even if it hadn’t declared itself yet.³⁵

Thyroidectomy for Persistent Symptoms

For the subset of patients who remain miserable despite normal thyroid levels on medication, surgical removal of the thyroid has emerged as a controversial but intriguing option. The logic is that as long as the thyroid tissue remains, it serves as a continuing target for the autoimmune attack, and the inflammation itself may be driving symptoms independently of hormone levels.

A randomized trial from Norway tested this directly. Euthyroid Hashimoto’s patients with persisting symptoms were randomly assigned to thyroidectomy or continued medical management. The results were striking: general health scores nearly doubled in the surgical group, chronic fatigue dropped from 82% to 35%, and anti-TPO antibody levels plummeted from a median of 2232 to 152.³⁶ The medically managed group showed no improvement over the same period. A scoping review covering 645 Hashimoto’s patients who underwent thyroidectomy for persistent symptoms found that every study reported improved quality of life after surgery.³⁷

This doesn’t mean thyroidectomy should become routine for Hashimoto’s. Surgery carries its own risks, including potential damage to the parathyroid glands and recurrent laryngeal nerve, and it commits you to lifelong thyroid hormone replacement rather than the possibility that your thyroid might partially recover. But for people who have exhausted other options and whose quality of life remains poor, the data increasingly suggest it deserves a place in the conversation.³⁸

A Brief Origin Story

The disease is named after Hakaru Hashimoto, a Japanese surgeon who in 1912 described what he called a distinct type of lymphomatous thyroid tumor. At the time, no one understood autoimmunity as a concept, and it took decades before researchers recognized that the pattern Hashimoto observed was actually the immune system attacking the thyroid rather than a tumor growing in it.³⁹ It was one of the very first diseases recognized as autoimmune in origin, and it helped establish the broader field of autoimmune disease research. More than a century later, researchers are still filling in the details of how the immune system goes wrong and, more importantly, how to fix the symptoms that standard treatment leaves behind.